Allianz: BarCap maintains 'overweight' rating
(CercleFinance.com) - Barclays Capital (BarCap) maintains its buy rating on the Allianz stock, along with its target price of 225 euros, saying that it is now more “constructive” towards the European insurance sector in 2019, having adopted a positive outlook for the sector.
"While global growth is slowing, our economists still expect the world's major economies to grow at or above trend in 2019, and risk assets are more attractively priced after the year-long pullback ," the broker says.
In this environment, BarCap believes that "consistent delivery of relative positive earnings and dividends revisions will continue, particularly as sector fundamentals improve".
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.
"While global growth is slowing, our economists still expect the world's major economies to grow at or above trend in 2019, and risk assets are more attractively priced after the year-long pullback ," the broker says.
In this environment, BarCap believes that "consistent delivery of relative positive earnings and dividends revisions will continue, particularly as sector fundamentals improve".
Copyright (c) 2018 CercleFinance.com. All rights reserved.
The information and analyses distributed by Cercle Finance are only intended as decision-making support for investors. Cercle Finance's responsibility may not be entailed, either directly or indirectly following the use of such information and analyses by readers. Any non-professional investor is recommended to consult a professional advisor before making any investment decision. This indicative information in no way constitutes any invitation to sell or buy securities.